0001640147-20-000007.txt : 20200707
0001640147-20-000007.hdr.sgml : 20200707
20200707190520
ACCESSION NUMBER: 0001640147-20-000007
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200702
FILED AS OF DATE: 20200707
DATE AS OF CHANGE: 20200707
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EHRLICH JASON
CENTRAL INDEX KEY: 0001754049
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38682
FILM NUMBER: 201016943
MAIL ADDRESS:
STREET 1: 2631 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kodiak Sciences Inc.
CENTRAL INDEX KEY: 0001468748
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 270476525
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2631 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
BUSINESS PHONE: 650-281-0850
MAIL ADDRESS:
STREET 1: 2631 HANOVER STREET
CITY: PALO ALTO
STATE: CA
ZIP: 94304
FORMER COMPANY:
FORMER CONFORMED NAME: Oligasis, LLC
DATE OF NAME CHANGE: 20090721
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2020-07-02
0
0001468748
Kodiak Sciences Inc.
KOD
0001754049
EHRLICH JASON
2631 HANOVER STREET
PALO ALTO
CA
94304
0
1
0
0
See Remarks
Common Stock
2020-07-02
4
M
0
2700
10.29
A
33984
D
Stock Option (Right to Buy)
10.29
2020-07-02
4
M
0
2700
0
A
2028-08-29
Common Stock
2700
393425
D
Twenty-five percent of the shares subject to the option vested on September 1, 2019 and 1/48th of the shares subject to the option vest on the same day of each month thereafter.
Chief Medical Officer and Chief Development Officer
/s/ Carlton Fleming, Attorney-in-Fact for Jason Ehrlich
2020-07-07